Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Endocrine|September 15, 2016
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclassesMartina Rossi, Sabrina Lupo, Roberta Rossi, et al.
Endocrinology|March 1, 2012
Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitroDaniela Molè, Erica Gentilin, Teresa Gagliano, et al.
Endocrine|February 4, 2015
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR regionSilvia Sambugaro, Mauro Di Ruvo, Maria Rosaria Ambrosio, et al.
Endocrine-Related Cancer|May 9, 2013
mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoidsTeresa Gagliano, Mariaenrica Bellio, Erica Gentilin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2006
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectivesMaria Chiara Zatelli, Daniela Piccin, Federico Tagliati, et al.
Endocrine-Related Cancer|June 18, 2010
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoidsMaria Chiara Zatelli, Mariella Minoia, Chiara Martini, et al.
Endocrine|April 10, 2015
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cellsDaniela Molè, Erica Gentilin, Alejandro Ibañez-Costa, et al.
Endocrine-Related Cancer|March 31, 2007
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretionMaria Chiara Zatelli, Daniela Piccin, Cristina Vignali, et al.
Pageof 5